Press releases
- Protalix BioTherapeutics to Present at the 2024 BIO International Convention
- Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results
- Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024
- Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results
- Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024
More ▼
Key statistics
On Friday, Protalix Biotherapeutics Inc (PBDA:DEU) closed at 1.01, 6.11% above its 52-week low of 0.95, set on May 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.05 |
---|---|
High | 1.05 |
Low | 1.01 |
Bid | 0.9976 |
Offer | 1.06 |
Previous close | 1.05 |
Average volume | 1.92k |
---|---|
Shares outstanding | 73.32m |
Free float | 62.63m |
P/E (TTM) | 18.62 |
Market cap | 82.85m USD |
EPS (TTM) | 0.0607 USD |
Data delayed at least 15 minutes, as of May 31 2024.
More ▼